Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERISCOPE trial: perioperative modified FOLFOXIRI in operable gastric cancer
2017-004500-22Phase 2Completed
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Start
- Mar 2018
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin, irinotecan, levoleucovorin and fluorouracil in gastric adenocarcinoma, sponsored by Gruppo Oncologico Italiano di Ricerca Clinica. Primary endpoint: Pathologic complete response after neoadjuvant treatment. Started Mar 2018; status: completed.
02
Drugs
oxaliplatinirinotecanlevoleucovorinfluorouracil
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on 2017-004500-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004500-22.